Integra LifeSciences (IART) Q1 2024 Earnings
IART·Reported May 6, 2024·Before market open
Integra LifeSciences reported Q1 2024 revenue of $368.9M, beat analyst consensus of $362.0M by $6.9M. Diluted EPS came in at $0.55.
Revenue
$368.9Mbeat by $6.9M
Consensus: $362.0MDiluted EPS
$0.55met estimate
Consensus: $0.55
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Integra LifeSciences's Q1 2024 earnings report.
Integra LifeSciences (IART) reported Q1 2024 earnings on May 6, 2024 before market open.
Integra LifeSciences reported revenue of $368.9M and diluted EPS of $0.55 for Q1 2024.
Revenue beat the consensus estimate of $362.0M by $6.9M. EPS beat the consensus estimate of $0.55 by $0.00.
You can read the 10-Q periodic report (0000917520-24-000061) directly on SEC EDGAR. The filing index links above go to sec.gov.